Neurological & Neurocognitive Complications

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

General / Neurocognitive Complications | Research

Show Archived (Historical) Articles

General / Neurocognitive Complications

Dementia and Nervous System Problems (November 22, 2008)
To read PDF, click here
From AIDS InfoNet
Neurological Complications of AIDS Fact Sheet (August 29, 2007)
From U.S. National Institutes of Health
NIH Allocates Funds to Study Drugs That Might Prevent Cognitive Dysfunctions Among HIV-Positive People (October 4, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Headache and HIV (Winter 2004/2005)
Gregory Pauxtis, M.D., discusses potential causes and treatments for headaches in people with HIV.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Neurological Complications of HIV/AIDS (Winter 2004/2005)
A clinical review by Venkat K. Rao, M.D., and Florian P. Thomas, M.D., M.A., Ph.D.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Life After Sustiva: Depression, Anxiety Side Effects (May/June 2004)
Gerry Hoyt is one of a small number of people who suffer severe, long-term psychological side effects while using efavirenz.
In Survival News, from AIDS Survival Project
Dizzy, Dreamy, Depressed: Dealing With Sustiva Side Effects (July/August 2003)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Neurologic Complications in HIV-Infected Children and Adolescents (March 2003)
To read PDF, click here
From New York State Department of Health AIDS Institute
The Central Nervous System and HIV (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project
Good News and Bad News on Neuromuscular Problems (November 2001)
In HIV Treatment ALERTS!, from The Center for AIDS
Cause and Effect: HIV Drugs May Stem Nerve Disorder (September 25, 2001)
In The New York Times
Current Views on Common Neurologic Manifestations of HIV (September 2000)
In The PRN Notebook
"Mental" Issue Threatens Medical Care (June 2, 2000)
Restrictions on "psychiatric" care mean that many patients with organic brain disease cannot be treated in the hospital wards equipped to manage the behavioral problems which may result from the illness.
In AIDS Treatment News, from AIDS Treatment News
What's New in Treatment Information? Myelopathy and HIV Infection (June 2000)
In What's New, from Project Inform
Communication Disorders and HIV Disease (April 1999)
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
SAMe As It Ever Was? (Spring 1999)
In Notes From the Underground, from PWA Health Group
HIV-1 Viral Load in the CSF and Brain (February 3, 1998)
From Seattle Treatment Education Project
Vitamin B-12 and Cognitive Impairment (September 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Interpretation of Cranial MRI Scans in AIDS (March 1997)
In Hopkins HIV Report, from Johns Hopkins AIDS Service
Review of AIDS and the Impact of Cognitive Impairment: A Treatment Guide for Mental Health Providers (June 1996)
By Penelope Zeifert, Ph.D., Mark Leary, M.D., and Alicia A. Boccellari, Ph.D.; reviewed by Cheryl S. Weinstein.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
Memantine Info Sheet (May 1996)
From PWA Health Group
Peptide T Info Sheet (May 1996)
From PWA Health Group

Research

Signs Emerge That Isentress May Temporarily Worsen Existing Depression (September 2, 2008)
From aidsmap.com
HIV-Positive On HAART Less Likely to Experience Brain Damage, Study Says (October 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIVers on Meds May Be Less Likely to Develop Brain Damage, Study Says (October 9, 2007)
In Neurology
HIV Treatment May Improve Brain Function in People With Advanced HIV, Study Finds (June 5, 2007)
From aidsmap.com
HIV JournalView: Efavirenz Has No Significant, Lasting Impact on Neuropsychological Performance (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
Higher Efavirenz Plasma Levels May Increase Neuropsychiatric Complication Risk (December 15, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
AIDS Reduces Brain Tissue in Certain Regions Despite HAART, Study Says (October 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Meth Use, HIV Infection Linked to Changes in Brain Structure That Can Impair Cognitive Functions, Study Says (August 15, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Minocycline May Have Protective Effect Against HIV-Related Neurological Complications, Research Suggests (July/August 2005)
Intriguing findings reported in SIV-infected monkeys receiving this inexpensive antibiotic.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Neuropsychiatric Symptoms From Efavirenz Not Always Time-Limited (May/June 2005)
More than half of 120 Spanish patients report persistent, though usually mild, symptoms after nearly two years.
From The Body PRO
The Genomics of Efavirenz Toxicity (January 2005)
Part of HIV JournalView's Top 10 Research Reports of 2004.
In The 12th International AIDS Conference, from The Body PRO
Previous Alcohol Abuse May Reduce HIV Patients' Cognitive Function (March 18, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Neurologic Side Effects of Efavirenz Not Affected by the Drug's Blood Levels (March/April 2004)
In Positively Aware, from Test Positive Aware Network
HIVers Over 50 at Increased Risk of Cognitive Impairment, Even With HAART (February 19, 2004)
From aidsmap.com
Dementia: Brain Damage Found in HIV Patients on Antiretroviral Therapy (January 16, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Acquired Immunodeficiency Syndrome and the Risk of Stroke (December 18, 2003)
Abstract of a U.S. study finding a greatly increased likelihood of stroke among AIDS patients.
In Stroke
Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion (November 2003)
Abstract of a study in the Archives of Neurology.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
ACTG 5097s: Efavirenz-Related CNS Events in the 5095 Study (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Memory Problems Increase Patients' Wish to Die (June 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Efavirenz More Durable Than Nevirapine, But CNS Toxicity Underestimated (April 29, 2003)
British researchers find that efavirenz works better over the long term, but that its psychiatric side effects persist a lot longer than previously thought.
From aidsmap.com
Psychiatric and Neuropsychiatric Manifestations of HIV Infection (April 4, 2003)
A slide presentation by Ewald Horwath, M.D.
Crossing the Blood-Brain Barrier (Summer 2002)
Vitamin C may help many medications more effectively reach the brain.
In Women Alive Newsletter, from Women Alive
HIV Infection May Trigger Neurologic Disorder (January/February 2002)
In Body Positive, from Body Positive
Cerebrospinal Fluid HIV-1 RNA Levels Peak During Primary HIV-1 Infection (February 5, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Gender and Neurological Functioning in HIV Infection (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.